Keiichi Fujiwara

Saitama International Medical Center — Japan

Medicine · Health Sciences

59h-index17.2kcitations662works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(289), Endometrial and Cervical Cancer Treatments(107), PARP inhibition in cancer therapy(97), Intraperitoneal and Appendiceal Malignancies(59), Lung Cancer Treatments and Mutations(49)

Publications621 total

Successful Placement of a Silicone Y‐Stent Using the Pullback Technique Through a Self‐Expandable Metallic Stent in a Case of Tuberculous Airway Stenosis
Respirology Case Reports·2025Open Access
GOG-3119/ENGOT-EN29/TROFUSE-033: A PHASE 3, RANDOMIZED STUDY OF SACITUZUMAB TIRUMOTECAN PLUS PEMBROLIZUMAB VS PEMBROLIZUMAB ALONE AS FIRST-LINE MAINTENANCE THERAPY FOR MISMATCH REPAIR-PROFICIENT ENDOMETRIAL CANCER
International Journal of Gynecological Cancer·2025
SAFETY OF RUCAPARIB MONOTHERAPY IN ADVANCED HIGH-GRADE OVARIAN CANCER CLINICAL TRIALS
International Journal of Gynecological Cancer·2025
REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH ADVANCED PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CANCER WITHIN THE UNITED STATES: AN ANALYSIS OF SECONDARY DATA
International Journal of Gynecological Cancer·2025
LENVATINIB PLUS PEMBROLIZUMAB VERSUS TREATMENT OF PHYSICIAN’S CHOICE IN PARTICIPANTS WITH ADVANCED ENDOMETRIAL CANCER: 5-YEAR OUTCOMES FROM STUDY 309/KEYNOTE-775
International Journal of Gynecological Cancer·2025
RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer
Scientific Reports·2025Open Access
Recurrent Thymoma Diagnosed by Endobronchial Ultrasound‐Guided Fine‐Needle Aspiration: A Case Report
Respirology Case Reports·2025Open Access
Subglottic Stenosis After <scp>COVID</scp> ‐19 Mimicking Bronchial Asthma, Treated by Bronchoscopic Resection
Respirology Case Reports·2025Open Access
1073P 5-year progression-free survival (PFS) with rucaparib (RUCA) maintenance in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO (GOG-3020/ENGOT-ov45)
Annals of Oncology·2025
Chemotherapy with or without pembrolizumab followed by maintenance with olaparib or placebo for first-line treatment of advanced BRCA nonmutated epithelial ovarian cancer: Results from the randomized phase III ENGOT-OV43/GOG-3036/KEYLYNK-001 study
Gynecologic Oncology·2025· 3 cited
1071P Phase III, randomized, double-blind, placebo (Pbo)-controlled ENGOT-ov43/GOG-3036/KEYLYNK-001 study of 1L chemotherapy (CT) ± pembrolizumab (pembro) then maintenance (Maint) pembro ± olaparib (Ola) for advanced BRCA-nonmutated epithelial ovarian cancer (EOC): Analysis by HRD status
Annals of Oncology·2025Open Access
Diagnosis of right upper lobe lesion using the SUKEDACHI balloon with thin-bronchoscope to facilitate close-to-lesion transbronchial biopsy: Novel bronchoscopic technique
Respiratory Investigation·2025· 1 cited
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer
JCO Precision Oncology·2025Open Access
Customised Dumon Y‐Stent With Reversed Orientation for Management of Complex Airway Obstruction in Endobronchial Non‐Small‐Cell Lung Cancer: Clinical Image of a Successful Airway Salvage
Respirology Case Reports·2025Open Access
Self‐Expectoration of Airway Stent Following Chemoimmunotherapy in Extensive Disease Small Cell Lung Cancer
Respirology Case Reports·2025Open Access
Genomic instability score (GIS) and benefit from olaparib (ola) and bevacizumab (bev) maintenance in high-grade ovarian cancer (HGOC): Phase III PAOLA-1 GINECO/ENGOT-ov25 trial exploratory analysis.
Journal of Clinical Oncology·2025
HR-SC—an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
ESMO Open·2025· 1 citedOpen Access
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study
UNC Libraries·2025Open Access
Lorlatinib Induced Non-cardiogenic Pulmonary Edema
Internal Medicine·2025Open Access
Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review
Cancer Treatment Reviews·2025· 7 cited
page 1 of 32Next →

Frequent Co-authors

Ignace Vergote(12), Nicoletta Colombo(11), Bradley J. Monk(11), Amit M. Oza(10), Sandro Pignata(9), Isabelle Ray‐Coquard(8), Domenica Lorusso(7), Giovanni Scambia(7), Éric Pujade-Lauraine(7), Philipp Harter(7), Andrés Poveda(7), Robert L. Coleman(7), Thomas J. Herzog(7), Kosei Hasegawa(7), Michael Friedländer(6), Diane Provencher(6), Andreas du Bois(6), Ana Oaknin(6), Jonathan A. Ledermann(5), Susana Banerjee(5)